IOVAIovance Biotherapeutics, Inc.
$14.61+613% 1Y
$14.61
$1.8152 weeks$14.79
Is the price fair?
What IOVA's price assumes
Iovance Biotherapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 7.13× revenue.
7.13
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.69
Price / book · today's price, fiscal year to Dec 31, 2025
- EV / sales
- 6.01
EV / sales
Details›
- Price / booktoday's price, fiscal year to Dec 31, 2025
- 2.69
- EV / EBIToperating margin −93%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, fiscal year to Dec 31, 2025
- 6.01
- Market capitalisation
- $1.88B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks